Suppression of adjuvant arthritis and synovial macrophage inducible nitric oxide by N-iminoethyl-L-ornithine, a nitric oxide synthase inhibitor

Inflammation

Volumn 21, Issue 3, 1997, Pages 299-311

  Santos, Leilani L ^a   Morand, Eric F ^a   Yang, Yuanhang ^a   Hutchinson, Paul ^a   Holdsworth, Stephen R ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMINOETHYLORNITHINE; N IMINOETHYLORNITHINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CELL COUNT; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG EFFECT; INFLAMMATORY DISEASE; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MALE; NONHUMAN; RAT; SYNOVIAL FLUID; SYNOVIOCYTE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ENZYME INHIBITORS; HYPERSENSITIVITY, DELAYED; INFLAMMATION MEDIATORS; MACROPHAGES; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SYNOVIAL MEMBRANE;

ANIMALIA;

EID: 0030825765     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027397816209     Document Type: Article

References (37)

1. MONCADA S., R. M. J. PALMER, and E. A. HIGGS. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142.
2. + from a terminal guanidino nitrogen atom of L-arginine: a molecular mechanism regulating cellular proliferation that targets intracellular iron. In NO from L-arginine: a Bioregulatory system. Ed. Moncada S. and Higgs E. A. pp. 189-223. Amsterdam: Elsevier.
3. HIBBS, J. B. JR, R. R. TAINTOR, A. VAVRIN, and E. M. RACHLIN. 1988. NO: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157:87-94.
4. MCCALL T. B., N. K. BOUGHTON-SMITH, R. M. J. PALMER, B. J. R. WHITTLE, and S. MONCADA. 1989. Synthesis of NO from L-arginine by neutrophils. Release and interaction with Superoxide anion. Biochem. J. 261:293-296.
5. WEI, X. Q., I. G. CHARLES, A. SMITH, J. URE, G. FENY, F. HUANG, D. XU., W. MULLER, S. MONCADA, and F. Y. LLEW. 1992. Altered immune response in mice lacking iNOS. Nature 375:408-411.
6. HOFFMAN, R. A., J. M. LANGREHR, T. R. BILLAR, R. D. CURRAN, and R. L. SIMMONS. 1990. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J. Immunol. 145:2220-2226.
7. KUBES, T., M. SUZUKI, and D. N. GRANGER. 1991. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U.S.A. 88:4651-4655.
8. MULLIGAN, M. S., S. MONCADA, and P. A. WARD. 1992. Protective effects of inhibitors of nitric oxide synthase in immune complex vasculitis. Br. J. Pharmacol. 107:1159-1162.
9. MAC MICKING, J. D., D. O. WILLENBORG, M. J. WEIDEMANN, K. A. ROCKETT, and W. B. COWDEN. 1992. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalotigenic T cells. J. Exp. Med. 176:303-310.
10. CATTEL, V. T. COOK, and S. MONCADA. 1990. Glomeruli synthesize nitrite in experimental nephrotoxic nephritis. Kidney Intl. 38:1056-1060.
11. FIRESTEIN, G. S. Rheumatoid synovitis and pannus. In Klippel, J. H., Dieppe P. A. (eds), 1994, Rheumatology, Mosby-Year Book, Philadelphia, 3.12.1-3.12.30.
12. FIRESTEIN, G. S. 1991. The immunopathogenesis of rheumatoid arthritis. Curr. Opin. Rheumatol. 3:398-406.
13. SANTOS L. and P. G. TIPPING. 1994. Attenuation of adjuvant arthritis in rats by treatment with oxygen radical scavengers. Immunol. Cell Biol. 72:406-414.
14. FARRELL, A. J., D. R. BLAKE, R. M. PALMER, and S. MONCADA. 1992. Increased concentration of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 51:219-222.
15. STICHTENOTH, D. O., F. M. GUTZKI, D. TSIKAS, N. SELVE, S. M. BODE-BOGER, R. H. BOGER, and J. C. FORLICH. 1994. Increased urinary nitrate excretion in rats with adjuvant arthritis. Ann. Rheum. Dis. 53:547-549.
16. CENCI, E., L. ROMANI, A. MENCACCI, R. SPACCAPELO, E. SCHIAFFELLA, P. PUCCETTI, and F. BISTONI. 1993. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur. J. Immunol. 23:1034-1038.
17. MORAND, E. F., P. HUTCHINSON, A. HARGREAVES, N. J. GOULDING, N. W. BOYCE, and S. R. HOLDSWORTH. 1995. Detection of intracellular lipocortin 1 in human leukocyte subsets. Clin. Immunol. Immunopathol. 76:195-202.
18. OSWALD, I. P., R. T. GAZZINELLI, and S. L. JAMES. 1992. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J. Immunol. 148:3578-3581.
19. LIEW F. Y., Y. LI, D. MOSS, C. PARKINSON, M. V. ROGERS, and S. MONCADA. 1991. Resistance to Leishmania major infection correlates with the induction of NOS in murine macrophages. Eur. J. Immunol. 21:3009-3014.
20. BELENKY, S. N., R. A. ROBBINS, and I. RUBINSTEIN. 1993. Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro. J. Leukocyte Biol. 53:498-503.
21. LEIBOVICH, S. J., P. J. POLVERINI, T. W. FONG, L. A. HARLOW, and A. E. KOCH. 1994. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc. Natl. Acad. Sci. U.S.A. 91:4190-4194.
22. DUGAS B., M. DJAVAD MOSSALAYI, C. DAMAIS, and J. P. KOLB. 1995. Nitric oxide production by human monocytes: evidence for a role of CD23. Immunol. Today 16:574-580.
23. HIBBS J. B., Z. VAVRIN, and R. R. TAINTOR. 1987. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138:550-565.
24. IALENTI, A., A. IANARO, S. MONCADA, and M. DI ROSA. 1992. Modulation of acute inflammation by endogenous nitric oxide. Eur. J. Pharmacol. 211:177-182.
25. CATTELL, V., P. LARGEN, E. DE HEER, and T. COOK. 1991. Glomeruli synthesize nitrite in active Heymann nephritis; the source is infiltrating macrophages. Kidney Intl. 40:847-851.
26. MULLIGAN, M. S., S. MONCADA, and P. A. WARD. 1992. Protective effects of inhibitors of NOS in immune complex-induced vasculitis. Br. J. Pharmacol. 107:1159-1162.
27. MCCARTNEY-FRANCIS, N., J. B. ALLEN, D. E. MIZEL, J. E. ALBINA. Q. W. XIE, C. F. NATHAN, and S. M. WAHL. 1993. Suppression of arthritis by an inhibitor of NOS. J. Exp. Med. 178:749-754.
28. REES, D. D., R. M. J. PALMER, R. SCHULZ, H. F. HODSON, and S. MONCADA. 1990. Characterization of three inhibitors of endothelial NOS in vitro and in vivo. Br. J. Pharmacol. 101:746-752.
29. MCCALL, T. B., FEELISCH, M., PALMER, R. M. J., and MONCADA, S. 1991. Identification of L-NIO as an irreversible inhibitor of NOS in phagocytic cells. Br. J. Pharmacol. 102:234-238.
30. STEFANOVIC-RACIC M., K. MEYERS, C. MESCHTER, J. W. COFFEY, R. A. HOFFMAN, and C. H. EVANS. 1994. N-Monomethyl-L-arginine, an inhibitor of NOS, suppresses the development of AA in rats. Arthritis Rheum 37:1062-1069.
31. + and Superoxide radical are involved in both initiation and development of AA in rats. Life Sci. 54:285-289.
32. IALENTI, A., S. MONCADA, and M. DI ROSA. 1993. Modulation of AA by endogenous NO. Br. J. Pharmacol. 110:701-706.
33. KLEBANOFF S. J. and C. F. NATHAN. 1993. Nitrite production by stimulated human polymorphonuclear leukocytes supplemented with azide and catalase. Biochem. Biophys. Res. Commun. 197:192-196.
34. BECKMAN J. S., T. W. BECKMAN, J. CHEN, and P. A. MARSHALL. 1990. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and Superoxide. Proc. Natl. Acad. Sci. U.S.A. 87:1620-1624.
35. SANTOS, L. L., E. F. MORAND, P. HUTCHINSON, N. W. BOYCE, and S. R. HOLDSWORTH. 1997. Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis. Clin. Exp. Immunol. 107:248-254.
36. SAKURAI, H., H. KOHSAKA, M.-F. LIU, H. HIGASHIYAMA, Y. HIRATA, K. KANNO, I. SAITO, and N. MlYASAKA. 1995. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J. Clin. Invest. 96:2357-2363.
37. TASKIRAN, D., M. STEFANOVIC-RACIC, H. GEORGESCU, C. EVANS. 1994. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem. Biophys. Res. Commun. 200:142-148.